CFO interim

TransCode Therapeutics, Inc. names John Tattory interim CFO

TransCode Therapeutics, Inc. reported in a Form 8-K filed September 11, 2026 that John Tattory was named Interim Chief Financial Officer, principal financial officer and principal accounting officer, effective September 9, 2026.

In the filing's words

John Tattory was appointed to serve as the Company’s Interim Chief Financial Officer, principal financial officer and principal accounting officer, effective as of September 9, 2026. Beginning September 9, 2026, Mr. Tattory will provide his services as a consultant through Stout Risius Ross, LLC (“Stout”) at an agreed upon hourly rate.

Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.

CompanyTransCode Therapeutics, Inc. (RNAZ)
EventInterim
IncomingJohn Tattory
OutgoingThomas A. Fitzgerald, M.B.A.
Title in the filingInterim Chief Financial Officer, principal financial officer and principal accounting officer
EffectiveSeptember 9, 2026
8-K filedSeptember 11, 2026
Internal promotionNot established by the source
SEC CIK0001829635

TransCode Therapeutics, Inc. reported this change in a Form 8-K, Item 5.02, filed September 11, 2026. The filing's own words are quoted above.

Same industry, September 2026

5

Other moves filed that month at companies the roster files under SIC “Pharmaceutical Preparations”.

6 weeks ago· 2026-09-30DeparturePTPI

Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein

6 weeks ago· 2026-09-28InterimGANX

Gain Therapeutics, Inc. names Gene Mack interim CFO

2 months ago· 2026-09-08TransitionKURA

Kura Oncology, Inc. CFO transition: Jennifer Fulk to succeed Troy E. Wilson, Ph.D., J.D.

2 months ago· 2026-09-03AppointmentLBRX

LB Pharmaceuticals Inc appoints Joseph M. Miller as CFO

2 months ago· 2026-09-01TransitionVRTX

Vertex Pharmaceuticals Incorporated CFO transition: Jonathan Poole to succeed Charles F. Wagner, Jr.

Sources

  • sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26

Something wrong about John Tattory? Send a correction with the primary source.